Journal
JOURNAL OF NATURAL PRODUCTS
Volume 72, Issue 2, Pages 280-283Publisher
AMER CHEMICAL SOC
DOI: 10.1021/np800338p
Keywords
-
Funding
- National Institutes of Health [TW00327]
- Medicines for Malaria Venture, Geneva, Switzerland
- United States National Institutes of Health [GM-65597]
Ask authors/readers for more resources
Okundoperoxide (1) was isolated by bioassay-guided fractionation of extracts from Scleria striatinux (syn. S. striatonux). The compound contains a cyclic endoperoxide structural moiety and possesses moderate antimalarial activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available